Loading...
OTCM
USAQ
Market cap3mUSD
Dec 05, Last price  
0.29USD
1D
-14.71%
1Q
62.19%
IPO
-3.33%
Name

QHSLab Inc

Chart & Performance

D1W1MN
OTCM:USAQ chart
P/E
P/S
1.53
EPS
Div Yield, %
Shrs. gr., 5y
13.72%
Rev. gr., 5y
%
Revenues
2m
+51.31%
000000000000000124,5321,414,4211,243,1861,408,9952,131,926
Net income
-259k
L-44.65%
-7,067-14,050-35,576-40,063-42,937-62,792-77,016-69,620-69,870-40,475-722,114-23,248-11,356-38,631-178,932-337,073-1,016,666-1,431,463-468,362-259,239
CFO
142k
P
-1,928-6,085-3,776-563-6460-3,000-2,500-12,068-18,375-38,035-13,929-105-39,533-134,838-165,564-354,738-350,994-159,627142,437

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes AllergiEnd, a diagnostic related product and allergen immunotherapy treatments to primary care physicians. Its products are designed to promote prevention, early detection, management, and reversal of chronic diseases. The company was formerly known as USA Equities Corp. and changed its name to QHSLab, Inc. in April 2022. QHSLab, Inc. has a strategic alliance with Medical License Factory, LLC. The company was incorporated in 1983 and is based in West Palm Beach, Florida.
IPO date
Jan 09, 2002
Employees
4
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT